Company / Book Value per Share
INOVIO PHARMACEUTICALS, INC. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.898
FY2025
5-year range
$1.839 / $10.543
FY2021-FY2025
Trend
-63.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from $0.035 in FY2019 to $10.543 in FY2023.
Based on SEC 10-K filings.
$1.898 in FY2025 with a 5-year CAGR of -16.0%.
Declined from $10.543 to $1.898 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- -16.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.0%, indicating a declining trend.
- In FY2025, book value per share decreased 63.1% year-over-year.
- Peak book value per share was recorded in FY2023.
- Lowest book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.898 | -63.1% |
| FY2024 | $5.148 | -51.2% |
| FY2023 | $10.543 | +473.4% |
| FY2022 | $1.839 | -25.5% |
| FY2021 | $2.468 | -45.8% |
| FY2020 | $4.549 | +12776.7% |
| FY2019 | $0.035 | -96.3% |
| FY2018 | $0.962 | -50.0% |
| FY2017 | $1.923 | +12.6% |
| FY2016 | $1.707 | -41.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026